Literature DB >> 27540984

Immunogenic cross-talk between dengue and Zika viruses.

Stephen C Harrison1.   

Abstract

Mesh:

Year:  2016        PMID: 27540984     DOI: 10.1038/ni.3539

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  11 in total

1.  Structures of immature flavivirus particles.

Authors:  Ying Zhang; Jeroen Corver; Paul R Chipman; Wei Zhang; Sergei V Pletnev; Dagmar Sedlak; Timothy S Baker; James H Strauss; Richard J Kuhn; Michael G Rossmann
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 2.  Neutralization and antibody-dependent enhancement of dengue viruses.

Authors:  Scott B Halstead
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

3.  Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.

Authors:  Lalita Priyamvada; Kendra M Quicke; William H Hudson; Nattawat Onlamoon; Jaturong Sewatanon; Srilatha Edupuganti; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Mark J Mulligan; Patrick C Wilson; Rafi Ahmed; Mehul S Suthar; Jens Wrammert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

4.  The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.

Authors:  F A Rey; F X Heinz; C Mandl; C Kunz; S C Harrison
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

5.  Cross-reacting antibodies enhance dengue virus infection in humans.

Authors:  Wanwisa Dejnirattisai; Amonrat Jumnainsong; Naruthai Onsirisakul; Patricia Fitton; Sirijitt Vasanawathana; Wannee Limpitikul; Chunya Puttikhunt; Carolyn Edwards; Thaneeya Duangchinda; Sunpetchuda Supasa; Kriangkrai Chawansuntati; Prida Malasit; Juthathip Mongkolsapaya; Gavin Screaton
Journal:  Science       Date:  2010-05-07       Impact factor: 47.728

6.  Recognition determinants of broadly neutralizing human antibodies against dengue viruses.

Authors:  Alexander Rouvinski; Pablo Guardado-Calvo; Giovanna Barba-Spaeth; Stéphane Duquerroy; Marie-Christine Vaney; Carlos M Kikuti; M Erika Navarro Sanchez; Wanwisa Dejnirattisai; Wiyada Wongwiwat; Ahmed Haouz; Christine Girard-Blanc; Stéphane Petres; William E Shepard; Philippe Desprès; Fernando Arenzana-Seisdedos; Philippe Dussart; Juthathip Mongkolsapaya; Gavin R Screaton; Félix A Rey
Journal:  Nature       Date:  2015-01-12       Impact factor: 49.962

Review 7.  The human antibody response to dengue virus infection.

Authors:  Wahala M P B Wahala; Aravinda M de Silva
Journal:  Viruses       Date:  2011-11-25       Impact factor: 5.048

8.  Immature dengue virus: a veiled pathogen?

Authors:  Izabela A Rodenhuis-Zybert; Hilde M van der Schaar; Júlia M da Silva Voorham; Heidi van der Ende-Metselaar; Huan-Yao Lei; Jan Wilschut; Jolanda M Smit
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

9.  A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Authors:  Wanwisa Dejnirattisai; Wiyada Wongwiwat; Sunpetchuda Supasa; Xiaokang Zhang; Xinghong Dai; Alexander Rouvinski; Amonrat Jumnainsong; Carolyn Edwards; Nguyen Than Ha Quyen; Thaneeya Duangchinda; Jonathan M Grimes; Wen-Yang Tsai; Chih-Yun Lai; Wei-Kung Wang; Prida Malasit; Jeremy Farrar; Cameron P Simmons; Z Hong Zhou; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2014-12-15       Impact factor: 25.606

10.  Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.

Authors:  Wanwisa Dejnirattisai; Piyada Supasa; Wiyada Wongwiwat; Alexander Rouvinski; Giovanna Barba-Spaeth; Thaneeya Duangchinda; Anavaj Sakuntabhai; Van-Mai Cao-Lormeau; Prida Malasit; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2016-06-23       Impact factor: 25.606

View more
  22 in total

1.  Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.

Authors:  Shannon R Esswein; Harry B Gristick; Andrea Jurado; Avery Peace; Jennifer R Keeffe; Yu E Lee; Alisa V Voll; Mohsan Saeed; Michel C Nussenzweig; Charles M Rice; Davide F Robbiani; Margaret R MacDonald; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-22       Impact factor: 11.205

2.  Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Authors:  Angel Balmaseda; Karin Stettler; Raquel Medialdea-Carrera; Damaris Collado; Xia Jin; José Victor Zambrana; Stefano Jaconi; Elisabetta Cameroni; Saira Saborio; Francesca Rovida; Elena Percivalle; Samreen Ijaz; Steve Dicks; Ines Ushiro-Lumb; Luisa Barzon; Patricia Siqueira; David W G Brown; Fausto Baldanti; Richard Tedder; Maria Zambon; A M Bispo de Filippis; Eva Harris; Davide Corti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

3.  A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.

Authors:  Jennifer R Keeffe; Koen K A Van Rompay; Priscilla C Olsen; Qiao Wang; Anna Gazumyan; Stephanie A Azzopardi; Dennis Schaefer-Babajew; Yu E Lee; Jackson B Stuart; Anil Singapuri; Jennifer Watanabe; Jodie Usachenko; Amir Ardeshir; Mohsan Saeed; Marianna Agudelo; Thomas Eisenreich; Stylianos Bournazos; Thiago Y Oliveira; Charles M Rice; Lark L Coffey; Margaret R MacDonald; Pamela J Bjorkman; Michel C Nussenzweig; Davide F Robbiani
Journal:  Cell Rep       Date:  2018-11-06       Impact factor: 9.423

4.  Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

Authors:  Davide F Robbiani; Leonia Bozzacco; Jennifer R Keeffe; Ricardo Khouri; Priscilla C Olsen; Anna Gazumyan; Dennis Schaefer-Babajew; Santiago Avila-Rios; Lilian Nogueira; Roshni Patel; Stephanie A Azzopardi; Lion F K Uhl; Mohsan Saeed; Edgar E Sevilla-Reyes; Marianna Agudelo; Kai-Hui Yao; Jovana Golijanin; Harry B Gristick; Yu E Lee; Arlene Hurley; Marina Caskey; Joy Pai; Thiago Oliveira; Elsio A Wunder; Gielson Sacramento; Nivison Nery; Cibele Orge; Federico Costa; Mitermayer G Reis; Neena M Thomas; Thomas Eisenreich; Daniel M Weinberger; Antonio R P de Almeida; Anthony P West; Charles M Rice; Pamela J Bjorkman; Gustavo Reyes-Teran; Albert I Ko; Margaret R MacDonald; Michel C Nussenzweig
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

5.  A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Jenny C Cardenas; Alex Hall; Omar G Perez; Lucio Cardenas; Adam Hartstone-Rose; Scott B Halstead; Tonya M Colpitts
Journal:  J Gen Virol       Date:  2017-07-08       Impact factor: 3.891

6.  CD8+ T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection.

Authors:  Huarong Huang; Shihua Li; Yongli Zhang; Xiaojuan Han; Baoqian Jia; Hongtao Liu; Dandan Liu; Shuguang Tan; Qihui Wang; Yuhai Bi; William J Liu; Baidong Hou; George Fu Gao; Fuping Zhang
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

7.  ADE-ing and Abetting Zika.

Authors:  Jinsheng Wen; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

8.  Evaluating Vaccination Strategies for Zika Virus in the Americas.

Authors:  David P Durham; Meagan C Fitzpatrick; Martial L Ndeffo-Mbah; Alyssa S Parpia; Nelson L Michael; Alison P Galvani
Journal:  Ann Intern Med       Date:  2018-04-03       Impact factor: 25.391

Review 9.  Potential mechanisms of Zika-linked microcephaly.

Authors:  Emily Merfeld; Lily Ben-Avi; Mason Kennon; Kara L Cerveny
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-04-06       Impact factor: 5.814

Review 10.  Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.

Authors:  Monica A McArthur
Journal:  Viruses       Date:  2017-06-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.